Bass, Berry & Sims released its 11th Annual Healthcare Fraud & Abuse Review in early February 2023. As a companion to the Review, we hosted a complimentary webinar which provided an overview and discussion of key focus areas covered in the Review.
Continue Reading Watch Now | Healthcare Fraud & Abuse Annual Review Webinar
Register Now | 8th Annual Nashville Healthcare Fraud Conference
Please join us for the 8th Annual Nashville Healthcare Fraud Conference hosted by Bass, Berry & Sims and the Tennessee Hospital Association. Eligible for more than seven hours of CLE credit (including ethics), this complimentary program will take place on December 8th in Nashville (full day). The conference will be broadcast virtually the mornings of December 15th and 16th.
Continue Reading Register Now | 8th Annual Nashville Healthcare Fraud Conference
Watch On-Demand | How to Submit a Stark Law Self-Disclosure Webinar
Watch the recording of our latest webinar, in which our panel of national healthcare fraud and abuse attorneys will discuss how to disclose a Stark Law violation to CMS.
Continue Reading Watch On-Demand | How to Submit a Stark Law Self-Disclosure Webinar
Healthcare How-To Instructional Webinar Series: How to Request an Advisory Opinion (and Why)
Join us for a webinar in which Matt Tormey, EVP Compliance and Risk, Chief Compliance Officer, Ensemble Health Partners, moderates a discussion with two former OIG officials in Bass, Berry & Sims’ healthcare practice group focusing on how, when, and why to submit an advisory opinion request.
[Virtual Event] Civil False Claims Act Conference
I am looking forward to speaking on a panel at the ABA’s 2022 Virtual Civil False Claims Act and Qui Tam Enforcement Institute titled “Hot Topics 2022: Focus on AKS/Stark” on June 9, 2022 from 1:00 PM – 2:00 PM EST. I will be joined by Gejaa Gobena, Partner, Hogan Lovells, Jennifer Verkamp, Partner, Morgan Verkamp, and Ro Srinivas, Senior Trial Counsel, Department of Justice, Civil Division, Commercial Litigation Branch (Fraud Section).
Continue Reading [Virtual Event] Civil False Claims Act Conference
Register Now: Healthcare Fraud & Abuse Annual Review Webinar Replay | April 5 at Noon CT
Earlier this year, Bass, Berry & Sims released the 10th annual Healthcare Fraud & Abuse Review examining important healthcare fraud developments in 2021.
As a companion to the Review, we will replay a complimentary webinar on Tuesday, April 5, 2022, from 1:00 p.m.-3:00 p.m. ET / 12:00 p.m.-2:00 p.m. CT / 10:00-12:00 a.m. PT, which will provide an overview and discussion of key focus areas covered in the Review.
[WEBINAR] Healthcare Fraud & Abuse Annual Review
Read the most recent issue of the Healthcare Fraud & Abuse Annual Review.
Continue Reading [WEBINAR] Healthcare Fraud & Abuse Annual Review
Seventh Annual Healthcare Fraud Conference Highlights Key Risk Areas and Enforcement Developments for Healthcare Providers
Bass, Berry & Sims and the Tennessee Hospital Association hosted the Seventh Annual Healthcare Fraud Conference on December 1 and 2. The virtual conference featured more than 40 speakers and 500 attendees from over 40 states and the District of Columbia.
“The healthcare industry remains under intense scrutiny, making it more important than ever for providers to stay up to date on the latest developments concerning the FCA and fraud and abuse,” said Brian Roark, chair of the Bass, Berry & Sims Healthcare Fraud Task Force. “This conference examines those developments, provides practical solutions, and forecasts the most pressing issues ahead for healthcare providers.”
Topics Covered During Conference
Day 1 sessions covered conducting effective investigative interviews, navigating privilege issues in investigations, building effective compliance programs, navigating challenges posed by whistleblowers, understanding recent Stark Law and Anti-Kickback Statute developments, and False Claims Act self-disclosure considerations.
Day 2 kicked off with a review of the past year’s key healthcare fraud developments and looked at the future of the False Claims Act. Other sessions covered litigating healthcare fraud enforcement cases, provider relief fund audits and investigations, navigating contractor audits and administrative enforcement remedies, and hot topics in healthcare fraud. The day concluded with a 90-minute healthcare fraud hypothetical.
Click to access a recording of the conference. On-demand CLE is available for those that are interested.
[Virtual Event] 7th Annual Healthcare Fraud Conference
The 7th Annual Healthcare Fraud Conference was hosted by Bass, Berry & Sims and the Tennessee Hospital Association. Because we are unable to provide an in-person forum due to ongoing concerns resulting from the COVID-19 pandemic, we once again hosted the conference virtually.
This year’s complimentary CLE program, provides the same caliber of practical advice, insight into significant fraud and abuse issues facing healthcare professionals, and thoughtful discussion from industry panelists for which this conference is known.
Topics include:
- Healthcare Fraud Year in Review
- Hot Topics in Healthcare Fraud: Today and Tomorrow
- The Future of the False Claims Act
- Provider Relief Fund Audits and Investigations
- Navigating Corporate Integrity Agreements and Administrative Remedies
- Litigating Healthcare Fraud Enforcement Cases
- Stark Law and Anti-Kickback Statute Enforcement Developments
- FCA Self-Disclosure Considerations
This year’s conference was held on Wednesday, December 1 and Thursday, December 2. To watch the conference on-demand, please click here.
Click here to view the agenda and presenters.
Continue Reading [Virtual Event] 7th Annual Healthcare Fraud Conference
[WEBINAR] Pfizer v. OIG – A Showdown: Prosecutions Involving Patient Assistance Programs
Pfizer lost a legal battle focused on the company’s financial assistance program against the Department of Health and Human Services Office of Inspector General (OIG) in the U.S. District Court for the Southern District of New York. The agency denied the pharmaceutical company’s request to vacate an OIG advisory opinion that effectively precludes the manufacturer